Pediatrix director plans sale of 6,000 shares

Pediatrix Medical Group, Inc. (MD) received a Form 144 notice indicating that director Laura Linynsky plans a Rule 144 sale of up to 6,000 shares of common stock.

Rhea-AI Filing Summary

Pediatrix Medical Group, Inc. (MD) received a Form 144 notice indicating that director Laura Linynsky plans a Rule 144 sale of up to 6,000 shares of common stock. The shares were acquired through stock plan activity, and Merrill Lynch is listed as the broker for the proposed transaction.

Key Figures

Shares proposed for sale: 6,000 shares Acquisition date of shares: May 8, 2026 Signature date: September 10, 2026

3 metrics

Shares proposed for sale 6,000 shares Common stock under a Rule 144 notice filed for account of director Laura Linynsky

Acquisition date of shares May 8, 2026 Date listed for stock plan activity through which the 6,000 shares were acquired

Signature date September 10, 2026 Date associated with the Form 144 notice signed by Laura Linynsky

Key Terms

Rule 144, Stock Plan Activity, Form 144

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Plan Activity financial

"Common | 05/08/2026 | Stock Plan Activity | Issuer"

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Pediatrix Medical Group (MD)?

It discloses that director Laura Linynsky plans a Rule 144 sale of up to 6,000 shares of Pediatrix Medical Group common stock, with Merrill Lynch listed as broker and the shares having been acquired through stock plan activity.

How many Pediatrix Medical Group (MD) shares are covered by this Form 144?

The notice covers a proposed sale of up to 6,000 shares of common stock for the account of director Laura Linynsky under Rule 144.

Who is the selling security holder in this Pediatrix Medical Group (MD) Form 144?

The selling security holder is Laura Linynsky, identified as a director of Pediatrix Medical Group, Inc., filing notice of an intended sale of up to 6,000 common shares under Rule 144.

How were the Pediatrix Medical Group (MD) shares to be sold acquired?

The 6,000 Pediatrix Medical Group common shares covered by the Form 144 were acquired through Stock Plan Activity from the issuer, with an acquisition date listed as May 8, 2026.

Which broker is named in the Pediatrix Medical Group (MD) Form 144 filing?

The filing lists Merrill Lynch as the broker for the proposed sale of 6,000 Pediatrix Medical Group common shares, with the shares listed on the NYSE according to the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:28 PM EDT Accepted by SEC EDGAR 09/10/2026 - 04:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001543891
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pediatrix Medical Group, Inc.
SEC File Number
Address of Issuer	1301 Concord Terrace Sunrise FLORIDA 33323
Phone	9543840175
Name of Person for Whose Account the Securities are To Be Sold	Laura Linynsky
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K ST NW Suite 800 Washington DC 20006	6000	160736	81253271	09/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/08/2026	Stock Plan Activity	Issuer			6000	05/08/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Laura Linynsky
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)